Benzapet dispersible tablets orally 2 hours to reach the peak blood concentration, half-life of 1.5 ~ 2 hours, 2 hours after taking to play the role of lipid-lowering, generally 1 ~ 2 weeks after taking blood tests and inspections, blood lipids can be reduced (mainly triglycerides). Benzafibrate is mainly used for the treatment of hypertriglyceridemia, hypercholesterolemia, mixed hyperlipidemia, Benzafibrate can not be used in patients with gallbladder disease, cholelithiasis, for hepatic insufficiency, renal insufficiency or primary biliary cirrhosis is prohibited. The most common adverse reactions of benzabepet are gastrointestinal discomfort, such as dyspepsia, anorexia, nausea, vomiting, feeling of fullness, stomach upset, etc. Other less common adverse reactions are headache, dizziness, fatigue, rash, occasional cholelithiasis and myositis, and elevation of blood aminotransferase. Benzafibrate should be taken after regular testing of blood lipids, liver and kidney function indicators, consult a physician to adjust the medication, do not be negligent, so as not to delay the condition.